We are live on ! Find out more
LWA

Lantern Wealth Advisors Portfolio holdings

AUM $218M
1-Year Est. Return 23.72%
This Fund
S&P 500
This Quarter Est. Return
+2.11%
1 Year Est. Return
+23.72%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$138M
AUM Growth
-$4.41M
Cap. Flow
-$2.94M
Cap. Flow %
-2.14%
Top 10 Hldgs %
36.08%
Holding
139
New
11
Increased
44
Reduced
50
Closed
9

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$1M
2
PAYX icon
Paychex
PAYX
+$845K
3
LLY icon
Eli Lilly
LLY
+$832K
4
IBM icon
IBM
IBM
+$788K
5
IVV icon
iShares Core S&P 500 ETF
IVV
+$625K

Sector Composition

Rank Sector Weight
1 Financials 12.89%
2 Technology 12.44%
3 Healthcare 6.45%
4 Communication Services 6.4%
5 Consumer Discretionary 5.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRWD icon
51
CrowdStrike
CRWD
$214B
$663K 0.48%
+6,916
New +$575K
IVW icon
52
iShares S&P 500 Growth ETF
IVW
$77.1B
$623K 0.45%
6,736
+1,452
+27% +$125K
BRK.A icon
53
Berkshire Hathaway Class A
BRK.A
$1.12T
$612K 0.44%
1
TXN icon
54
Texas Instruments
TXN
$254B
$603K 0.44%
3,100
CVS icon
55
CVS Health
CVS
$126B
$603K 0.44%
10,206
-16,064
-61% -$1M
VNQ icon
56
Vanguard Real Estate ETF
VNQ
$39.2B
$577K 0.42%
6,893
+14
+0.2% +$1.16K
XOM icon
57
ExxonMobil
XOM
$628B
$572K 0.41%
4,966
+4
+0.1% +$466
VT icon
58
Vanguard Total World Stock ETF
VT
$79.2B
$572K 0.41%
5,074
+25
+0.5% +$2.76K
GSUS icon
59
Goldman Sachs MarketBeta US Equity ETF
GSUS
$3.27B
$563K 0.41%
7,534
-250
-3% -$18K
NFLX icon
60
Netflix
NFLX
$309B
$560K 0.41%
8,300
+10
+0.1% +$625
BMY icon
61
Bristol-Myers Squibb
BMY
$130B
$560K 0.41%
13,478
+1,432
+12% +$64.1K
ELV icon
62
Elevance Health
ELV
$84.8B
$542K 0.39%
1,000
JWN
63
DELISTED
Nordstrom
JWN
$541K 0.39%
25,500
IEMG icon
64
iShares Core MSCI Emerging Markets ETF
IEMG
$156B
$534K 0.39%
9,978
-544
-5% -$28.7K
ABT icon
65
Abbott
ABT
$183B
$510K 0.37%
4,910
-250
-5% -$26.5K
SCHG icon
66
Schwab US Large-Cap Growth ETF
SCHG
$62.2B
$506K 0.37%
20,064
+432
+2% +$10.2K
AWK icon
67
American Water Works
AWK
$26.7B
$504K 0.37%
3,900
FEBW icon
68
AllianzIM U.S. Equity Buffer20 Feb ETF
FEBW
$199M
$499K 0.36%
16,823
-331
-2% -$9.63K
IYW icon
69
iShares US Technology ETF
IYW
$24.9B
$492K 0.36%
3,269
+369
+13% +$51K
DXCM icon
70
DexCom
DXCM
$31.2B
$488K 0.35%
4,300
+200
+5% +$25.3K
NSC icon
71
Norfolk Southern
NSC
$76.8B
$467K 0.34%
2,175
-100
-4% -$23.2K
DUK icon
72
Duke Energy
DUK
$96.2B
$463K 0.34%
4,622
+7
+0.2% +$700
XLE icon
73
State Street Energy Select Sector SPDR ETF
XLE
$37.6B
$447K 0.32%
9,798
-328
-3% -$15.3K
SPG icon
74
Simon Property Group
SPG
$72.9B
$436K 0.32%
2,875
-548
-16% -$80.7K
FNDX icon
75
Schwab Fundamental US Large Company Index ETF
FNDX
$27.2B
$436K 0.32%
19,539
+135
+0.7% +$2.98K

Similar funds

Lantern Wealth Advisors's Q2 2024 Portfolio in Review

As of Q2 2024, Lantern Wealth Advisors held 139 positions worth $138M, down 3.1% from $142M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Lantern Wealth Advisors's Q2 2024 filing shows 11 new, 44 increased, 50 reduced and 9 closed positions. Its largest new stake was CrowdStrike: 6,916 shares worth $663K. The largest sale was CVS Health, an estimated $1M.

By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 13% a quarter earlier, followed by Technology and Healthcare.

  • Lantern Wealth Advisors's largest Q2 2024 buy was CrowdStrike: 6,916 shares worth $663K.
  • Lantern Wealth Advisors added most to Schwab Short-Term US Treasury ETF in Q2 2024, an estimated $1.36M increase.
  • Lantern Wealth Advisors's biggest Q2 2024 reduction was CVS Health, cutting an estimated $1M.
  • Lantern Wealth Advisors fully exited Paychex in Q2 2024, selling an estimated $845K.
  • Lantern Wealth Advisors's ten largest holdings make up 36% of its $138M portfolio in Q2 2024.
  • Lantern Wealth Advisors opened 11 new positions and closed 9 in Q2 2024.
  • Lantern Wealth Advisors's portfolio value fell 3.1% quarter-over-quarter to $138M.

Based on Lantern Wealth Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.